| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Salivary Gland Neoplasms | 54 | 2024 | 304 | 14.050 |
Why?
|
| Biopsy, Fine-Needle | 104 | 2024 | 1118 | 10.370 |
Why?
|
| Thyroid Neoplasms | 96 | 2024 | 2332 | 9.320 |
Why?
|
| Salivary Glands | 30 | 2024 | 229 | 9.090 |
Why?
|
| Cytodiagnosis | 32 | 2023 | 447 | 5.760 |
Why?
|
| Adenocarcinoma, Follicular | 26 | 2024 | 323 | 5.260 |
Why?
|
| Thyroid Nodule | 33 | 2024 | 764 | 5.130 |
Why?
|
| Thyroid Gland | 36 | 2020 | 1168 | 4.800 |
Why?
|
| Papillomavirus Infections | 26 | 2023 | 1613 | 3.760 |
Why?
|
| Carcinoma, Adenoid Cystic | 12 | 2024 | 262 | 3.320 |
Why?
|
| Head and Neck Neoplasms | 35 | 2024 | 2895 | 3.290 |
Why?
|
| Carcinoma | 31 | 2024 | 2330 | 3.240 |
Why?
|
| Carcinoma, Squamous Cell | 40 | 2023 | 4026 | 3.150 |
Why?
|
| Carcinoma, Papillary | 28 | 2020 | 785 | 2.730 |
Why?
|
| Neoplasms | 27 | 2024 | 22170 | 2.370 |
Why?
|
| Oropharyngeal Neoplasms | 14 | 2023 | 491 | 2.090 |
Why?
|
| Adenoma, Pleomorphic | 10 | 2020 | 75 | 1.950 |
Why?
|
| Papillomaviridae | 17 | 2022 | 1119 | 1.900 |
Why?
|
| Immunohistochemistry | 58 | 2024 | 11076 | 1.670 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 6 | 2022 | 698 | 1.610 |
Why?
|
| Human papillomavirus 16 | 9 | 2022 | 267 | 1.480 |
Why?
|
| Paranasal Sinus Neoplasms | 6 | 2023 | 242 | 1.450 |
Why?
|
| Proto-Oncogene Proteins c-myb | 2 | 2024 | 79 | 1.410 |
Why?
|
| Parotid Neoplasms | 9 | 2019 | 157 | 1.380 |
Why?
|
| Precancerous Conditions | 11 | 2023 | 980 | 1.330 |
Why?
|
| Adenoma | 12 | 2021 | 2160 | 1.320 |
Why?
|
| Diagnosis, Differential | 72 | 2021 | 12974 | 1.310 |
Why?
|
| Thyroid Diseases | 6 | 2023 | 386 | 1.290 |
Why?
|
| Adenoma, Oxyphilic | 8 | 2024 | 148 | 1.280 |
Why?
|
| Ameloblastoma | 5 | 2023 | 42 | 1.270 |
Why?
|
| Sebaceous Gland Neoplasms | 3 | 2020 | 40 | 1.260 |
Why?
|
| Adenocarcinoma, Sebaceous | 2 | 2020 | 21 | 1.250 |
Why?
|
| DNA, Viral | 10 | 2022 | 2202 | 1.240 |
Why?
|
| Humans | 377 | 2024 | 761504 | 1.220 |
Why?
|
| Mandibular Neoplasms | 4 | 2019 | 130 | 1.180 |
Why?
|
| Oxyphil Cells | 8 | 2021 | 56 | 1.170 |
Why?
|
| Carcinoma, Mucoepidermoid | 9 | 2023 | 89 | 1.140 |
Why?
|
| Conjunctival Neoplasms | 2 | 2019 | 77 | 1.100 |
Why?
|
| Global Warming | 2 | 2024 | 79 | 1.080 |
Why?
|
| In Situ Hybridization | 9 | 2019 | 1900 | 1.060 |
Why?
|
| Tongue Neoplasms | 8 | 2024 | 183 | 1.050 |
Why?
|
| Pathology, Clinical | 6 | 2020 | 376 | 1.000 |
Why?
|
| Molecular Diagnostic Techniques | 6 | 2020 | 611 | 0.970 |
Why?
|
| Carcinoma, Neuroendocrine | 8 | 2020 | 339 | 0.960 |
Why?
|
| Medicine | 2 | 2023 | 942 | 0.940 |
Why?
|
| Mole Rats | 1 | 2024 | 28 | 0.940 |
Why?
|
| Jaw Neoplasms | 8 | 2019 | 70 | 0.940 |
Why?
|
| Adenolymphoma | 2 | 2022 | 10 | 0.860 |
Why?
|
| Ribonuclease III | 2 | 2024 | 279 | 0.840 |
Why?
|
| Carcinoma, Papillary, Follicular | 4 | 2019 | 60 | 0.820 |
Why?
|
| Nose Neoplasms | 5 | 2023 | 249 | 0.820 |
Why?
|
| Biopsy, Needle | 15 | 2017 | 1626 | 0.800 |
Why?
|
| Rhabdoid Tumor | 1 | 2024 | 210 | 0.790 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2024 | 384 | 0.780 |
Why?
|
| Insurance Carriers | 1 | 2023 | 156 | 0.780 |
Why?
|
| Gene Fusion | 6 | 2024 | 356 | 0.780 |
Why?
|
| Human papillomavirus 18 | 4 | 2018 | 125 | 0.780 |
Why?
|
| Dreams | 1 | 2023 | 146 | 0.780 |
Why?
|
| Neoplasms, Squamous Cell | 2 | 2012 | 95 | 0.780 |
Why?
|
| Dendritic Cell Sarcoma, Follicular | 2 | 2020 | 30 | 0.780 |
Why?
|
| Lymphatic Metastasis | 10 | 2024 | 2915 | 0.770 |
Why?
|
| Thyroidectomy | 16 | 2023 | 907 | 0.750 |
Why?
|
| Laryngeal Neoplasms | 10 | 2019 | 514 | 0.750 |
Why?
|
| Eye Neoplasms | 2 | 2020 | 307 | 0.730 |
Why?
|
| Carcinoma, Endometrioid | 3 | 2016 | 276 | 0.730 |
Why?
|
| Climate Change | 2 | 2024 | 501 | 0.730 |
Why?
|
| Adenocarcinoma, Clear Cell | 6 | 2021 | 217 | 0.700 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 4 | 2023 | 58 | 0.700 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2024 | 1115 | 0.700 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2022 | 194 | 0.690 |
Why?
|
| Mouth Neoplasms | 5 | 2020 | 596 | 0.690 |
Why?
|
| Cytological Techniques | 3 | 2023 | 218 | 0.690 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2021 | 926 | 0.680 |
Why?
|
| Tonsillar Neoplasms | 1 | 2020 | 50 | 0.680 |
Why?
|
| Thyroiditis | 2 | 2019 | 86 | 0.670 |
Why?
|
| Aged, 80 and over | 58 | 2024 | 58976 | 0.670 |
Why?
|
| Middle Aged | 137 | 2024 | 220895 | 0.670 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2020 | 8547 | 0.650 |
Why?
|
| Aged | 113 | 2024 | 169289 | 0.650 |
Why?
|
| Alphapapillomavirus | 4 | 2022 | 218 | 0.630 |
Why?
|
| Male | 167 | 2024 | 360804 | 0.630 |
Why?
|
| Proto-Oncogene Proteins B-raf | 8 | 2023 | 2057 | 0.630 |
Why?
|
| Standard of Care | 1 | 2022 | 551 | 0.630 |
Why?
|
| Carcinoma, Acinar Cell | 6 | 2022 | 62 | 0.630 |
Why?
|
| Female | 175 | 2024 | 392644 | 0.630 |
Why?
|
| Odontogenic Tumors | 4 | 2024 | 45 | 0.630 |
Why?
|
| Carcinoma, Small Cell | 2 | 2019 | 420 | 0.630 |
Why?
|
| Lymph Nodes | 6 | 2018 | 3466 | 0.610 |
Why?
|
| Polymerase Chain Reaction | 9 | 2017 | 6075 | 0.610 |
Why?
|
| Graves Disease | 1 | 2019 | 238 | 0.600 |
Why?
|
| Sequence Analysis, RNA | 3 | 2024 | 2020 | 0.600 |
Why?
|
| Adult | 117 | 2024 | 221177 | 0.590 |
Why?
|
| Endometrial Neoplasms | 6 | 2016 | 1366 | 0.590 |
Why?
|
| Proto-Oncogene Proteins c-kit | 5 | 2014 | 727 | 0.590 |
Why?
|
| Goals | 1 | 2023 | 711 | 0.580 |
Why?
|
| RNA, Neoplasm | 1 | 2020 | 750 | 0.580 |
Why?
|
| Odontogenic Cysts | 4 | 2023 | 42 | 0.570 |
Why?
|
| Algorithms | 7 | 2023 | 14031 | 0.570 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 117 | 0.570 |
Why?
|
| Patient Care | 2 | 2022 | 622 | 0.560 |
Why?
|
| Histiocytosis, Langerhans-Cell | 2 | 2013 | 169 | 0.560 |
Why?
|
| Urinalysis | 1 | 2019 | 368 | 0.550 |
Why?
|
| Neoplasms, Multiple Primary | 3 | 2016 | 592 | 0.550 |
Why?
|
| Pancreas | 1 | 2023 | 1691 | 0.550 |
Why?
|
| Terminology as Topic | 5 | 2019 | 1530 | 0.550 |
Why?
|
| Mastoiditis | 1 | 2016 | 37 | 0.530 |
Why?
|
| Parotid Diseases | 3 | 2017 | 49 | 0.510 |
Why?
|
| Giant Cell Tumor of Bone | 5 | 2019 | 118 | 0.510 |
Why?
|
| Retrospective Studies | 65 | 2024 | 80636 | 0.510 |
Why?
|
| Oncogene Proteins, Fusion | 9 | 2024 | 1606 | 0.500 |
Why?
|
| Reproducibility of Results | 17 | 2021 | 20098 | 0.500 |
Why?
|
| Proto-Oncogene Proteins c-ret | 5 | 2021 | 225 | 0.490 |
Why?
|
| Nasolacrimal Duct | 1 | 2016 | 79 | 0.490 |
Why?
|
| Meningioma | 1 | 2024 | 1218 | 0.490 |
Why?
|
| Maxillary Neoplasms | 3 | 2016 | 47 | 0.490 |
Why?
|
| Meningeal Neoplasms | 1 | 2024 | 1248 | 0.480 |
Why?
|
| Sensitivity and Specificity | 19 | 2024 | 14666 | 0.480 |
Why?
|
| Papillomavirus E7 Proteins | 3 | 2021 | 109 | 0.480 |
Why?
|
| Keratins | 6 | 2009 | 498 | 0.480 |
Why?
|
| Mutation | 19 | 2024 | 30052 | 0.480 |
Why?
|
| Paranasal Sinuses | 3 | 2012 | 265 | 0.470 |
Why?
|
| Genes, myb | 1 | 2013 | 18 | 0.460 |
Why?
|
| Research Personnel | 1 | 2019 | 588 | 0.460 |
Why?
|
| Patient Education as Topic | 1 | 2024 | 2319 | 0.460 |
Why?
|
| Patient-Centered Care | 1 | 2024 | 1421 | 0.450 |
Why?
|
| Medical Records | 2 | 2019 | 1408 | 0.450 |
Why?
|
| Insurance, Health | 2 | 2023 | 2498 | 0.450 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2014 | 101 | 0.450 |
Why?
|
| Predictive Value of Tests | 22 | 2021 | 15266 | 0.440 |
Why?
|
| Immune System Diseases | 1 | 2016 | 256 | 0.440 |
Why?
|
| Gene Rearrangement | 6 | 2021 | 1125 | 0.440 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2023 | 17904 | 0.440 |
Why?
|
| Hyperplasia | 4 | 2014 | 1152 | 0.430 |
Why?
|
| Neoplasm Invasiveness | 13 | 2020 | 3595 | 0.430 |
Why?
|
| Communication | 2 | 2024 | 3873 | 0.430 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 4 | 2020 | 1092 | 0.420 |
Why?
|
| Motivation | 1 | 2023 | 2006 | 0.420 |
Why?
|
| Temporal Bone | 6 | 2019 | 683 | 0.420 |
Why?
|
| Nasal Cavity | 5 | 2023 | 304 | 0.410 |
Why?
|
| Gene Expression Profiling | 7 | 2020 | 9420 | 0.410 |
Why?
|
| Chondromatosis, Synovial | 3 | 2022 | 17 | 0.410 |
Why?
|
| Retinoblastoma | 1 | 2015 | 317 | 0.410 |
Why?
|
| Ear Neoplasms | 3 | 2020 | 118 | 0.400 |
Why?
|
| Parotid Gland | 5 | 2018 | 175 | 0.400 |
Why?
|
| Suicide | 1 | 2023 | 1601 | 0.400 |
Why?
|
| Vocal Cords | 6 | 2019 | 522 | 0.400 |
Why?
|
| Skull Neoplasms | 3 | 2019 | 173 | 0.400 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2022 | 2825 | 0.400 |
Why?
|
| Bone Neoplasms | 7 | 2021 | 2529 | 0.390 |
Why?
|
| Biopsy | 15 | 2021 | 6766 | 0.390 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 2578 | 0.390 |
Why?
|
| Pathology | 3 | 2016 | 270 | 0.390 |
Why?
|
| Infratentorial Neoplasms | 1 | 2012 | 98 | 0.390 |
Why?
|
| Glossectomy | 5 | 2021 | 60 | 0.390 |
Why?
|
| RNA, Viral | 3 | 2019 | 2846 | 0.390 |
Why?
|
| Neoplasms, Complex and Mixed | 1 | 2011 | 35 | 0.380 |
Why?
|
| Young Adult | 36 | 2024 | 59243 | 0.380 |
Why?
|
| Tongue | 5 | 2023 | 403 | 0.380 |
Why?
|
| Mandible | 4 | 2015 | 753 | 0.370 |
Why?
|
| Cysts | 2 | 2007 | 681 | 0.370 |
Why?
|
| Public Health | 1 | 2024 | 2669 | 0.360 |
Why?
|
| Adolescent | 44 | 2024 | 88319 | 0.360 |
Why?
|
| Adenocarcinoma | 8 | 2024 | 6346 | 0.360 |
Why?
|
| Translocation, Genetic | 6 | 2022 | 1393 | 0.360 |
Why?
|
| Carcinoma in Situ | 1 | 2016 | 791 | 0.350 |
Why?
|
| Triage | 1 | 2017 | 986 | 0.350 |
Why?
|
| Turbinates | 2 | 2012 | 65 | 0.350 |
Why?
|
| Antigens, CD1 | 1 | 2012 | 439 | 0.340 |
Why?
|
| Receptor, trkA | 2 | 2020 | 159 | 0.330 |
Why?
|
| Health Services Accessibility | 2 | 2024 | 5440 | 0.330 |
Why?
|
| Nose Diseases | 4 | 2013 | 79 | 0.330 |
Why?
|
| Neoplasms, Second Primary | 2 | 2014 | 1052 | 0.320 |
Why?
|
| Ultrasonography | 11 | 2023 | 5972 | 0.320 |
Why?
|
| Temporomandibular Joint Disorders | 3 | 2022 | 222 | 0.320 |
Why?
|
| Teratoma | 2 | 2023 | 404 | 0.320 |
Why?
|
| Prognosis | 25 | 2023 | 29625 | 0.320 |
Why?
|
| Clinical Trials as Topic | 2 | 2024 | 8002 | 0.320 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2008 | 59 | 0.310 |
Why?
|
| Myoepithelioma | 2 | 2021 | 26 | 0.310 |
Why?
|
| Salivary Glands, Minor | 2 | 2019 | 25 | 0.310 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2014 | 612 | 0.310 |
Why?
|
| Pancreatic Neoplasms | 2 | 2022 | 5368 | 0.300 |
Why?
|
| Adenomatous Polyposis Coli | 2 | 2007 | 218 | 0.300 |
Why?
|
| Estrogen Receptor alpha | 3 | 2021 | 582 | 0.300 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2008 | 38 | 0.300 |
Why?
|
| Neck | 7 | 2024 | 734 | 0.300 |
Why?
|
| Orbital Diseases | 3 | 2011 | 178 | 0.300 |
Why?
|
| Mandibular Condyle | 3 | 2020 | 115 | 0.300 |
Why?
|
| Laser Therapy | 4 | 2011 | 1092 | 0.290 |
Why?
|
| Mediastinitis | 1 | 2007 | 49 | 0.290 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2008 | 86 | 0.290 |
Why?
|
| Biomedical Research | 1 | 2023 | 3429 | 0.290 |
Why?
|
| Eustachian Tube | 2 | 2021 | 99 | 0.280 |
Why?
|
| Osteogenesis, Distraction | 3 | 2015 | 227 | 0.280 |
Why?
|
| Ear Diseases | 2 | 2014 | 180 | 0.280 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2021 | 487 | 0.280 |
Why?
|
| Cryptococcosis | 1 | 2007 | 104 | 0.270 |
Why?
|
| Parathyroid Diseases | 1 | 2006 | 46 | 0.270 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 4544 | 0.270 |
Why?
|
| Optic Neuritis | 1 | 2008 | 174 | 0.270 |
Why?
|
| Antineoplastic Agents | 7 | 2024 | 13639 | 0.270 |
Why?
|
| DNA Mutational Analysis | 7 | 2021 | 4111 | 0.270 |
Why?
|
| Sjogren's Syndrome | 2 | 2019 | 237 | 0.260 |
Why?
|
| Submandibular Gland Neoplasms | 2 | 2019 | 10 | 0.260 |
Why?
|
| Ethmoid Sinus | 1 | 2006 | 57 | 0.260 |
Why?
|
| Neoplasm Metastasis | 9 | 2021 | 4915 | 0.260 |
Why?
|
| Parathyroid Glands | 3 | 2008 | 518 | 0.260 |
Why?
|
| In Situ Hybridization, Fluorescence | 8 | 2022 | 2510 | 0.260 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 2016 | 767 | 0.260 |
Why?
|
| Paraffin Embedding | 4 | 2016 | 302 | 0.250 |
Why?
|
| Glottis | 3 | 2019 | 214 | 0.250 |
Why?
|
| Laryngoscopy | 4 | 2011 | 706 | 0.250 |
Why?
|
| Automation, Laboratory | 2 | 2016 | 102 | 0.250 |
Why?
|
| Vaginal Smears | 3 | 2003 | 499 | 0.250 |
Why?
|
| Paraganglioma | 2 | 2020 | 142 | 0.250 |
Why?
|
| Biocompatible Materials | 4 | 2019 | 1685 | 0.240 |
Why?
|
| Specimen Handling | 2 | 2020 | 702 | 0.240 |
Why?
|
| Hamartoma | 3 | 2013 | 235 | 0.240 |
Why?
|
| Endocrinology | 2 | 2021 | 442 | 0.240 |
Why?
|
| Planets | 1 | 2024 | 7 | 0.240 |
Why?
|
| United States | 14 | 2023 | 72334 | 0.230 |
Why?
|
| Laryngectomy | 1 | 2006 | 243 | 0.230 |
Why?
|
| Neck Muscles | 3 | 2015 | 100 | 0.230 |
Why?
|
| Cell Nucleus | 6 | 2018 | 2909 | 0.230 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2024 | 76 | 0.230 |
Why?
|
| Pathology, Surgical | 4 | 2016 | 151 | 0.220 |
Why?
|
| Abscess | 1 | 2007 | 606 | 0.220 |
Why?
|
| Microsatellite Repeats | 4 | 2000 | 784 | 0.220 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2024 | 72 | 0.220 |
Why?
|
| Neoplasms, Connective and Soft Tissue | 1 | 2023 | 34 | 0.220 |
Why?
|
| Endosonography | 1 | 2007 | 609 | 0.220 |
Why?
|
| Vision Disorders | 2 | 2008 | 1088 | 0.220 |
Why?
|
| Chemokine CXCL9 | 1 | 2023 | 135 | 0.220 |
Why?
|
| Ethicists | 1 | 2023 | 39 | 0.220 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 3639 | 0.220 |
Why?
|
| Eosinophilia | 2 | 2023 | 560 | 0.210 |
Why?
|
| Carcinoma, Ductal | 2 | 2021 | 97 | 0.210 |
Why?
|
| Skin Neoplasms | 7 | 2016 | 5821 | 0.210 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2020 | 4580 | 0.210 |
Why?
|
| Transcription Factors | 11 | 2022 | 12128 | 0.210 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2019 | 781 | 0.200 |
Why?
|
| Sinusitis | 3 | 2008 | 991 | 0.200 |
Why?
|
| Neoplasm Recurrence, Local | 14 | 2023 | 9280 | 0.200 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2003 | 384 | 0.200 |
Why?
|
| Metabolomics | 1 | 2011 | 1659 | 0.200 |
Why?
|
| Submandibular Gland | 2 | 2019 | 87 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 24 | 2022 | 20570 | 0.200 |
Why?
|
| Frozen Sections | 2 | 2016 | 153 | 0.200 |
Why?
|
| Indocyanine Green | 1 | 2023 | 233 | 0.190 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 3877 | 0.190 |
Why?
|
| Sphenoid Sinus | 1 | 2002 | 99 | 0.190 |
Why?
|
| Pandemics | 2 | 2022 | 8654 | 0.190 |
Why?
|
| Osteopontin | 1 | 2023 | 301 | 0.190 |
Why?
|
| Hyperparathyroidism | 1 | 2003 | 337 | 0.190 |
Why?
|
| Dendritic Cells | 1 | 2012 | 2747 | 0.190 |
Why?
|
| Parathyroid Neoplasms | 1 | 2003 | 242 | 0.190 |
Why?
|
| Lipids | 1 | 2012 | 3341 | 0.190 |
Why?
|
| Receptors, Steroid | 1 | 2022 | 156 | 0.190 |
Why?
|
| International Cooperation | 2 | 2020 | 1422 | 0.190 |
Why?
|
| Practice Guidelines as Topic | 7 | 2018 | 7390 | 0.190 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2024 | 455 | 0.180 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2021 | 61 | 0.180 |
Why?
|
| Viral Tropism | 1 | 2021 | 102 | 0.180 |
Why?
|
| Child | 29 | 2022 | 80153 | 0.180 |
Why?
|
| Scalp | 2 | 2016 | 389 | 0.180 |
Why?
|
| Receptor, trkC | 1 | 2020 | 63 | 0.180 |
Why?
|
| Palatine Tonsil | 1 | 2021 | 193 | 0.180 |
Why?
|
| Chondrosarcoma | 2 | 2000 | 296 | 0.180 |
Why?
|
| Biology | 1 | 2023 | 290 | 0.180 |
Why?
|
| Bronchial Neoplasms | 1 | 2021 | 110 | 0.180 |
Why?
|
| Pharynx | 1 | 2023 | 432 | 0.180 |
Why?
|
| Amylases | 1 | 2020 | 171 | 0.180 |
Why?
|
| Uterine Cervical Diseases | 1 | 2001 | 73 | 0.180 |
Why?
|
| Genes, ras | 3 | 2017 | 654 | 0.180 |
Why?
|
| Carcinosarcoma | 1 | 2021 | 106 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2021 | 2547 | 0.180 |
Why?
|
| Rare Diseases | 2 | 2024 | 622 | 0.180 |
Why?
|
| Durapatite | 2 | 2019 | 163 | 0.180 |
Why?
|
| Health Facilities | 2 | 2023 | 580 | 0.180 |
Why?
|
| Molecular Targeted Therapy | 3 | 2020 | 2811 | 0.180 |
Why?
|
| Hashimoto Disease | 2 | 2012 | 105 | 0.180 |
Why?
|
| Genetic Heterogeneity | 2 | 2021 | 732 | 0.170 |
Why?
|
| Giant Cell Tumors | 2 | 2012 | 89 | 0.170 |
Why?
|
| Blood Proteins | 4 | 1990 | 1173 | 0.170 |
Why?
|
| Cell Polarity | 1 | 2023 | 637 | 0.170 |
Why?
|
| Consensus | 5 | 2022 | 3123 | 0.170 |
Why?
|
| Neoplasm Staging | 14 | 2020 | 11121 | 0.170 |
Why?
|
| Ear, Middle | 1 | 2002 | 339 | 0.170 |
Why?
|
| Genetic Testing | 2 | 2023 | 3537 | 0.170 |
Why?
|
| Hyaluronic Acid | 3 | 2019 | 483 | 0.170 |
Why?
|
| Observer Variation | 7 | 2020 | 2606 | 0.170 |
Why?
|
| Lung Neoplasms | 3 | 2019 | 13380 | 0.170 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2006 | 1116 | 0.160 |
Why?
|
| Calcinosis | 2 | 2007 | 1469 | 0.160 |
Why?
|
| Ear Canal | 1 | 2020 | 147 | 0.160 |
Why?
|
| Temporomandibular Joint | 2 | 2022 | 201 | 0.160 |
Why?
|
| Thyroglobulin | 2 | 2009 | 111 | 0.160 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2019 | 38 | 0.160 |
Why?
|
| Laboratories, Hospital | 1 | 2020 | 192 | 0.160 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2024 | 2803 | 0.160 |
Why?
|
| Asia | 1 | 2020 | 619 | 0.160 |
Why?
|
| Glaucoma | 1 | 2008 | 1185 | 0.160 |
Why?
|
| False Positive Reactions | 2 | 2019 | 957 | 0.160 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2018 | 2020 | 0.160 |
Why?
|
| Ultrasonography, Doppler | 2 | 2019 | 462 | 0.160 |
Why?
|
| Salivary Ducts | 2 | 2012 | 25 | 0.160 |
Why?
|
| Facial Nerve | 2 | 2019 | 277 | 0.160 |
Why?
|
| Chemokines, CXC | 1 | 2020 | 422 | 0.160 |
Why?
|
| Colon | 1 | 2006 | 1792 | 0.160 |
Why?
|
| Drugs, Generic | 1 | 2024 | 448 | 0.160 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 703 | 0.160 |
Why?
|
| ras Proteins | 2 | 2017 | 1054 | 0.150 |
Why?
|
| Stromal Cells | 4 | 2019 | 1330 | 0.150 |
Why?
|
| Risk | 3 | 2016 | 9610 | 0.150 |
Why?
|
| Carcinoma, Medullary | 3 | 2011 | 115 | 0.150 |
Why?
|
| Journal Impact Factor | 1 | 2020 | 153 | 0.150 |
Why?
|
| International Agencies | 2 | 2019 | 243 | 0.150 |
Why?
|
| Maxillary Sinus Neoplasms | 1 | 2018 | 39 | 0.150 |
Why?
|
| Metaplasia | 2 | 2011 | 322 | 0.150 |
Why?
|
| Endolymphatic Sac | 1 | 2018 | 49 | 0.150 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2024 | 214 | 0.150 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2019 | 92 | 0.150 |
Why?
|
| Reference Standards | 2 | 2019 | 1003 | 0.150 |
Why?
|
| Nasopharynx | 1 | 2021 | 401 | 0.150 |
Why?
|
| Oropharynx | 1 | 2019 | 138 | 0.150 |
Why?
|
| Neoplasm Proteins | 4 | 2018 | 3617 | 0.150 |
Why?
|
| Rhinitis | 1 | 2006 | 747 | 0.150 |
Why?
|
| Epithelium | 3 | 2021 | 1603 | 0.150 |
Why?
|
| Facial Bones | 1 | 2019 | 208 | 0.150 |
Why?
|
| Endometrium | 2 | 2000 | 403 | 0.150 |
Why?
|
| Specialization | 1 | 2023 | 778 | 0.150 |
Why?
|
| Erythropoietin | 2 | 1993 | 719 | 0.150 |
Why?
|
| Colonic Neoplasms | 2 | 2006 | 2538 | 0.150 |
Why?
|
| Fasciitis | 1 | 2018 | 67 | 0.150 |
Why?
|
| Fixatives | 2 | 2016 | 90 | 0.150 |
Why?
|
| Radiography, Panoramic | 2 | 2015 | 118 | 0.150 |
Why?
|
| Antigens, CD34 | 3 | 2009 | 658 | 0.150 |
Why?
|
| Fluorescent Dyes | 2 | 2023 | 1903 | 0.150 |
Why?
|
| Adaptation, Physiological | 1 | 2024 | 1301 | 0.140 |
Why?
|
| RANK Ligand | 1 | 2019 | 318 | 0.140 |
Why?
|
| Communicable Disease Control | 2 | 2022 | 846 | 0.140 |
Why?
|
| Submandibular Gland Diseases | 1 | 2017 | 22 | 0.140 |
Why?
|
| Famous Persons | 1 | 2018 | 109 | 0.140 |
Why?
|
| Salivary Gland Diseases | 3 | 2017 | 37 | 0.140 |
Why?
|
| Mediastinum | 1 | 2018 | 267 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 1745 | 0.140 |
Why?
|
| Orbit | 1 | 2020 | 457 | 0.140 |
Why?
|
| Mesenchymoma | 2 | 2024 | 49 | 0.140 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2017 | 106 | 0.140 |
Why?
|
| Laboratories | 1 | 2020 | 458 | 0.140 |
Why?
|
| Meniere Disease | 1 | 2018 | 164 | 0.140 |
Why?
|
| Cervix Uteri | 1 | 2001 | 570 | 0.140 |
Why?
|
| Nasal Obstruction | 4 | 2012 | 160 | 0.140 |
Why?
|
| Macrophages | 3 | 2023 | 5769 | 0.140 |
Why?
|
| Analysis of Variance | 5 | 2012 | 6228 | 0.140 |
Why?
|
| Italy | 2 | 2017 | 842 | 0.140 |
Why?
|
| Epithelial Cells | 2 | 2020 | 3673 | 0.140 |
Why?
|
| Myeloid Cells | 1 | 2021 | 823 | 0.130 |
Why?
|
| Hemangiosarcoma | 1 | 2018 | 215 | 0.130 |
Why?
|
| Jaw Cysts | 1 | 2016 | 8 | 0.130 |
Why?
|
| Otitis Media | 1 | 2018 | 286 | 0.130 |
Why?
|
| Netherlands | 1 | 2021 | 2221 | 0.130 |
Why?
|
| Polychondritis, Relapsing | 1 | 2016 | 29 | 0.130 |
Why?
|
| Tyrosine | 1 | 2020 | 1440 | 0.130 |
Why?
|
| Gingival Neoplasms | 1 | 2016 | 20 | 0.130 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2016 | 25 | 0.130 |
Why?
|
| Ganglion Cysts | 1 | 2016 | 28 | 0.130 |
Why?
|
| Tracheal Neoplasms | 1 | 2017 | 123 | 0.130 |
Why?
|
| Ganglioneuroma | 1 | 2016 | 53 | 0.130 |
Why?
|
| beta Catenin | 1 | 2021 | 1040 | 0.130 |
Why?
|
| Laryngoplasty | 1 | 2016 | 50 | 0.130 |
Why?
|
| Thyroglossal Cyst | 1 | 2015 | 31 | 0.130 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2016 | 113 | 0.130 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2018 | 290 | 0.130 |
Why?
|
| Synovial Cyst | 1 | 2016 | 35 | 0.130 |
Why?
|
| Tumor Burden | 3 | 2017 | 1893 | 0.130 |
Why?
|
| Science | 1 | 2018 | 239 | 0.130 |
Why?
|
| Finger Phalanges | 1 | 2016 | 41 | 0.130 |
Why?
|
| Workflow | 2 | 2022 | 851 | 0.130 |
Why?
|
| Fatal Outcome | 4 | 2018 | 1834 | 0.130 |
Why?
|
| Incidental Findings | 1 | 2020 | 697 | 0.130 |
Why?
|
| U937 Cells | 1 | 2015 | 261 | 0.130 |
Why?
|
| Neck Dissection | 1 | 2017 | 201 | 0.130 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2015 | 66 | 0.120 |
Why?
|
| Child, Preschool | 13 | 2022 | 42230 | 0.120 |
Why?
|
| Protein Kinase C | 2 | 1993 | 1202 | 0.120 |
Why?
|
| Facial Paralysis | 1 | 2019 | 346 | 0.120 |
Why?
|
| Membrane Proteins | 5 | 2024 | 7856 | 0.120 |
Why?
|
| Amyloidosis | 1 | 2002 | 817 | 0.120 |
Why?
|
| Follow-Up Studies | 16 | 2020 | 39106 | 0.120 |
Why?
|
| Endoscopy | 5 | 2013 | 1851 | 0.120 |
Why?
|
| Dogs | 5 | 2019 | 3839 | 0.120 |
Why?
|
| Tissue Fixation | 1 | 2016 | 241 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 4 | 2012 | 1705 | 0.120 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2000 | 710 | 0.120 |
Why?
|
| Treatment Outcome | 25 | 2021 | 64680 | 0.120 |
Why?
|
| Protein Kinases | 2 | 2020 | 1608 | 0.120 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 681 | 0.120 |
Why?
|
| Diglycerides | 2 | 1993 | 177 | 0.120 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2023 | 1159 | 0.120 |
Why?
|
| Iodine Radioisotopes | 3 | 2024 | 1031 | 0.120 |
Why?
|
| Receptor, Notch1 | 1 | 2017 | 496 | 0.120 |
Why?
|
| Workload | 1 | 2020 | 844 | 0.120 |
Why?
|
| False Negative Reactions | 2 | 2014 | 573 | 0.120 |
Why?
|
| Respiratory Tract Infections | 1 | 2022 | 1010 | 0.120 |
Why?
|
| Formaldehyde | 1 | 2016 | 358 | 0.120 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2016 | 340 | 0.120 |
Why?
|
| Cohort Studies | 11 | 2020 | 41487 | 0.120 |
Why?
|
| Patient Selection | 2 | 2024 | 4244 | 0.120 |
Why?
|
| Erythrocyte Membrane | 4 | 1990 | 439 | 0.120 |
Why?
|
| PPAR gamma | 1 | 2017 | 484 | 0.120 |
Why?
|
| Antigens, Viral | 1 | 2018 | 988 | 0.110 |
Why?
|
| Hyperpigmentation | 2 | 2012 | 117 | 0.110 |
Why?
|
| Zygoma | 2 | 2011 | 52 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1229 | 0.110 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1993 | 817 | 0.110 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2018 | 732 | 0.110 |
Why?
|
| Vaccination | 2 | 2024 | 3384 | 0.110 |
Why?
|
| Phosphoproteins | 3 | 2006 | 2448 | 0.110 |
Why?
|
| Myoblasts | 2 | 2006 | 231 | 0.110 |
Why?
|
| Balloon Occlusion | 1 | 2014 | 125 | 0.110 |
Why?
|
| Fear | 1 | 2022 | 1476 | 0.110 |
Why?
|
| Risk Assessment | 10 | 2019 | 23995 | 0.110 |
Why?
|
| Single-Cell Analysis | 2 | 2022 | 2449 | 0.110 |
Why?
|
| Calcimycin | 1 | 1993 | 213 | 0.110 |
Why?
|
| Electrosurgery | 2 | 2010 | 51 | 0.110 |
Why?
|
| Spinal Puncture | 1 | 2015 | 282 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 1386 | 0.110 |
Why?
|
| Mouth Floor | 1 | 2013 | 38 | 0.110 |
Why?
|
| DNA, Neoplasm | 5 | 2011 | 1745 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 6484 | 0.110 |
Why?
|
| Papillomavirus Vaccines | 1 | 2019 | 496 | 0.110 |
Why?
|
| Otologic Surgical Procedures | 1 | 2014 | 150 | 0.100 |
Why?
|
| Animals | 27 | 2024 | 168459 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2010 | 1405 | 0.100 |
Why?
|
| Mycoses | 2 | 2008 | 386 | 0.100 |
Why?
|
| Skull Base Neoplasms | 1 | 2016 | 270 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2020 | 2612 | 0.100 |
Why?
|
| Sarcoma | 1 | 2023 | 1801 | 0.100 |
Why?
|
| Europe | 2 | 2020 | 3422 | 0.100 |
Why?
|
| Combined Modality Therapy | 9 | 2015 | 8529 | 0.100 |
Why?
|
| Dermoid Cyst | 1 | 2013 | 92 | 0.100 |
Why?
|
| Genes, Neoplasm | 1 | 2014 | 370 | 0.100 |
Why?
|
| Ultrasonics | 2 | 2010 | 208 | 0.100 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2018 | 938 | 0.100 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 10194 | 0.100 |
Why?
|
| Cranial Nerve Diseases | 1 | 2012 | 113 | 0.100 |
Why?
|
| Case-Control Studies | 4 | 2022 | 22176 | 0.100 |
Why?
|
| Vacuoles | 1 | 2012 | 228 | 0.100 |
Why?
|
| Granuloma | 2 | 2011 | 328 | 0.100 |
Why?
|
| Nuclear Proteins | 5 | 2022 | 5796 | 0.100 |
Why?
|
| Neoplasm, Residual | 1 | 2016 | 1008 | 0.100 |
Why?
|
| RNA-Binding Protein EWS | 2 | 2024 | 210 | 0.100 |
Why?
|
| Minocycline | 1 | 2012 | 169 | 0.100 |
Why?
|
| Herpesvirus 4, Human | 2 | 2014 | 1078 | 0.090 |
Why?
|
| Laryngeal Mucosa | 1 | 2011 | 32 | 0.090 |
Why?
|
| Neurilemmoma | 2 | 2019 | 526 | 0.090 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2011 | 42 | 0.090 |
Why?
|
| Physician-Patient Relations | 1 | 2024 | 3249 | 0.090 |
Why?
|
| Nasal Mucosa | 2 | 2012 | 416 | 0.090 |
Why?
|
| Paralysis | 1 | 2012 | 250 | 0.090 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 2011 | 64 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2010 | 695 | 0.090 |
Why?
|
| Incidence | 4 | 2023 | 21353 | 0.090 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2011 | 84 | 0.090 |
Why?
|
| Sarcoma, Myeloid | 1 | 2011 | 51 | 0.090 |
Why?
|
| Mucins | 2 | 2022 | 568 | 0.090 |
Why?
|
| Facial Dermatoses | 1 | 2011 | 86 | 0.090 |
Why?
|
| Pilomatrixoma | 1 | 2010 | 24 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 5492 | 0.090 |
Why?
|
| Mouth Diseases | 1 | 2013 | 241 | 0.090 |
Why?
|
| Radiography | 5 | 2013 | 6965 | 0.090 |
Why?
|
| Phenotype | 6 | 2020 | 16591 | 0.090 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2011 | 134 | 0.090 |
Why?
|
| Disease-Free Survival | 3 | 2018 | 6814 | 0.090 |
Why?
|
| Fluorescence | 2 | 2023 | 756 | 0.090 |
Why?
|
| Hospitals | 1 | 2024 | 3882 | 0.090 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2015 | 392 | 0.090 |
Why?
|
| Mucous Membrane | 1 | 2013 | 659 | 0.090 |
Why?
|
| Histocytochemistry | 2 | 2022 | 698 | 0.080 |
Why?
|
| Human papillomavirus 11 | 1 | 2009 | 14 | 0.080 |
Why?
|
| Sclerosis | 2 | 2007 | 210 | 0.080 |
Why?
|
| Ear, External | 1 | 2010 | 165 | 0.080 |
Why?
|
| Cell Hypoxia | 1 | 1992 | 656 | 0.080 |
Why?
|
| Bacitracin | 1 | 2009 | 24 | 0.080 |
Why?
|
| Opportunistic Infections | 1 | 2012 | 376 | 0.080 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 2009 | 56 | 0.080 |
Why?
|
| Cholesteatoma | 1 | 2009 | 28 | 0.080 |
Why?
|
| Intraoperative Period | 2 | 2017 | 510 | 0.080 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2009 | 48 | 0.080 |
Why?
|
| Decanoates | 2 | 2008 | 55 | 0.080 |
Why?
|
| Phonation | 1 | 2011 | 220 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 2021 | 2986 | 0.080 |
Why?
|
| Soft Tissue Injuries | 1 | 2011 | 172 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2019 | 2220 | 0.080 |
Why?
|
| Telepathology | 1 | 2009 | 77 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 1363 | 0.080 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2010 | 297 | 0.080 |
Why?
|
| Medicaid | 1 | 2022 | 2818 | 0.080 |
Why?
|
| Cell Differentiation | 4 | 2015 | 11528 | 0.080 |
Why?
|
| Decision Making | 1 | 2023 | 3929 | 0.080 |
Why?
|
| Prospective Studies | 12 | 2023 | 54425 | 0.080 |
Why?
|
| Lasers, Solid-State | 1 | 2011 | 176 | 0.080 |
Why?
|
| Facial Neoplasms | 1 | 2009 | 125 | 0.080 |
Why?
|
| Vagus Nerve | 1 | 2011 | 458 | 0.080 |
Why?
|
| Plasma Cells | 1 | 2012 | 599 | 0.080 |
Why?
|
| Immunocompetence | 1 | 2008 | 138 | 0.080 |
Why?
|
| Papilloma | 1 | 2009 | 140 | 0.080 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 943 | 0.080 |
Why?
|
| Aorta | 1 | 2016 | 2042 | 0.080 |
Why?
|
| Foreign-Body Reaction | 1 | 2009 | 157 | 0.080 |
Why?
|
| Nasal Septum | 1 | 2009 | 130 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2009 | 2917 | 0.080 |
Why?
|
| Lizards | 1 | 2008 | 50 | 0.080 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 5336 | 0.080 |
Why?
|
| Glycerol | 2 | 2008 | 274 | 0.080 |
Why?
|
| DNA-Binding Proteins | 4 | 2022 | 9606 | 0.070 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2011 | 542 | 0.070 |
Why?
|
| Palatal Neoplasms | 1 | 2007 | 37 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 1896 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1459 | 0.070 |
Why?
|
| Swine, Miniature | 3 | 2015 | 961 | 0.070 |
Why?
|
| Disease Progression | 5 | 2020 | 13506 | 0.070 |
Why?
|
| Osteoma | 1 | 2006 | 12 | 0.070 |
Why?
|
| Remote Consultation | 1 | 2009 | 237 | 0.070 |
Why?
|
| Prosthesis Implantation | 1 | 2011 | 592 | 0.070 |
Why?
|
| Thyroid Function Tests | 2 | 2022 | 288 | 0.070 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2007 | 67 | 0.070 |
Why?
|
| Cryptococcus neoformans | 1 | 2007 | 121 | 0.070 |
Why?
|
| Gene Expression | 1 | 2019 | 7581 | 0.070 |
Why?
|
| Erythropoiesis | 1 | 1990 | 683 | 0.070 |
Why?
|
| Logistic Models | 3 | 2019 | 13255 | 0.070 |
Why?
|
| Models, Animal | 4 | 2015 | 2112 | 0.070 |
Why?
|
| Physicians | 1 | 2024 | 4591 | 0.070 |
Why?
|
| Tissue Adhesives | 1 | 2008 | 173 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2008 | 535 | 0.070 |
Why?
|
| Colloids | 1 | 2006 | 123 | 0.070 |
Why?
|
| Fetus | 1 | 2013 | 1863 | 0.070 |
Why?
|
| Diagnostic Imaging | 3 | 2021 | 3530 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2019 | 3548 | 0.060 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 3201 | 0.060 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2006 | 186 | 0.060 |
Why?
|
| Fibroma | 1 | 2007 | 190 | 0.060 |
Why?
|
| Hyalin | 2 | 2019 | 34 | 0.060 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2006 | 89 | 0.060 |
Why?
|
| Brain | 1 | 2012 | 27112 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 3080 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 1496 | 0.060 |
Why?
|
| Pathology, Molecular | 2 | 2019 | 328 | 0.060 |
Why?
|
| Hydrogels | 1 | 2011 | 720 | 0.060 |
Why?
|
| Duodenal Neoplasms | 1 | 2006 | 114 | 0.060 |
Why?
|
| Sciatic Neuropathy | 1 | 2005 | 76 | 0.060 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 1189 | 0.060 |
Why?
|
| Glycosaminoglycans | 1 | 2008 | 607 | 0.060 |
Why?
|
| Guided Tissue Regeneration | 1 | 2005 | 88 | 0.060 |
Why?
|
| Laryngeal Diseases | 1 | 2008 | 243 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2022 | 2856 | 0.060 |
Why?
|
| Angiomyoma | 1 | 2004 | 11 | 0.060 |
Why?
|
| Skin | 2 | 2016 | 4484 | 0.060 |
Why?
|
| Respiratory Mucosa | 1 | 2008 | 439 | 0.060 |
Why?
|
| Schwann Cells | 1 | 2005 | 197 | 0.060 |
Why?
|
| Photochemotherapy | 1 | 2011 | 823 | 0.060 |
Why?
|
| Immunotherapy | 2 | 2018 | 4652 | 0.060 |
Why?
|
| Fiber Optic Technology | 1 | 2006 | 290 | 0.060 |
Why?
|
| Muscle Neoplasms | 1 | 2005 | 130 | 0.060 |
Why?
|
| Bronchogenic Cyst | 1 | 2004 | 28 | 0.060 |
Why?
|
| Time Factors | 9 | 2021 | 39967 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3778 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2018 | 36426 | 0.060 |
Why?
|
| Ireland | 1 | 2024 | 170 | 0.060 |
Why?
|
| Lung | 2 | 2022 | 10000 | 0.060 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2024 | 191 | 0.060 |
Why?
|
| Kinetics | 4 | 2022 | 6374 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 2 | 2006 | 1342 | 0.060 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 736 | 0.060 |
Why?
|
| Sarcoidosis | 1 | 2009 | 521 | 0.060 |
Why?
|
| Ointments | 2 | 2016 | 58 | 0.050 |
Why?
|
| Recurrence | 1 | 2016 | 8465 | 0.050 |
Why?
|
| Swine | 4 | 2015 | 5915 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2019 | 1784 | 0.050 |
Why?
|
| Nasal Polyps | 1 | 2008 | 395 | 0.050 |
Why?
|
| Lymphoma, Follicular | 1 | 2007 | 457 | 0.050 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2024 | 257 | 0.050 |
Why?
|
| Orbital Pseudotumor | 1 | 2003 | 42 | 0.050 |
Why?
|
| S100 Proteins | 1 | 2023 | 218 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 1988 | 1170 | 0.050 |
Why?
|
| PAX7 Transcription Factor | 2 | 2014 | 55 | 0.050 |
Why?
|
| Cisplatin | 1 | 2009 | 1651 | 0.050 |
Why?
|
| Boston | 1 | 2015 | 9326 | 0.050 |
Why?
|
| Connective Tissue | 2 | 2015 | 419 | 0.050 |
Why?
|
| Kidney Neoplasms | 2 | 2016 | 4249 | 0.050 |
Why?
|
| Injections | 2 | 2019 | 830 | 0.050 |
Why?
|
| Keratinocytes | 1 | 2006 | 790 | 0.050 |
Why?
|
| MyoD Protein | 2 | 2014 | 142 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2003 | 615 | 0.050 |
Why?
|
| Tritium | 2 | 1993 | 708 | 0.050 |
Why?
|
| Eosinophilic Granuloma | 1 | 2002 | 27 | 0.050 |
Why?
|
| Cystitis | 1 | 2002 | 95 | 0.050 |
Why?
|
| Cicatrix | 1 | 2008 | 798 | 0.050 |
Why?
|
| Radioimmunoassay | 2 | 1993 | 862 | 0.050 |
Why?
|
| Polymers | 2 | 2008 | 1617 | 0.050 |
Why?
|
| Rectum | 1 | 2006 | 892 | 0.050 |
Why?
|
| Bone Regeneration | 2 | 2015 | 432 | 0.050 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2014 | 283 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2024 | 5305 | 0.050 |
Why?
|
| Societies, Medical | 3 | 2020 | 3905 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2011 | 2571 | 0.050 |
Why?
|
| Cell Proliferation | 5 | 2020 | 10445 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3769 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2006 | 1510 | 0.050 |
Why?
|
| BK Virus | 1 | 2002 | 123 | 0.050 |
Why?
|
| Oral Surgical Procedures | 1 | 2003 | 166 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1405 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 16981 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 255 | 0.050 |
Why?
|
| Equipment Design | 2 | 2006 | 3510 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2016 | 12795 | 0.050 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2022 | 199 | 0.050 |
Why?
|
| Erythrocytes | 1 | 1990 | 2413 | 0.050 |
Why?
|
| Oncogene Fusion | 1 | 2021 | 81 | 0.050 |
Why?
|
| GTP Phosphohydrolases | 1 | 2024 | 517 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2017 | 9177 | 0.050 |
Why?
|
| Cartilage | 2 | 2015 | 806 | 0.050 |
Why?
|
| Radicular Cyst | 1 | 2000 | 12 | 0.050 |
Why?
|
| Dentigerous Cyst | 1 | 2000 | 18 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 1993 | 1545 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 3164 | 0.040 |
Why?
|
| Neuropeptides | 1 | 1986 | 944 | 0.040 |
Why?
|
| Pregnancy | 1 | 2022 | 29874 | 0.040 |
Why?
|
| Cell Lineage | 3 | 2016 | 2555 | 0.040 |
Why?
|
| Hemangioma | 1 | 2005 | 727 | 0.040 |
Why?
|
| Medical Oncology | 2 | 2022 | 2321 | 0.040 |
Why?
|
| Curettage | 1 | 2000 | 74 | 0.040 |
Why?
|
| Infant | 7 | 2022 | 36192 | 0.040 |
Why?
|
| Random Allocation | 3 | 2011 | 2395 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2021 | 314 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2013 | 6132 | 0.040 |
Why?
|
| Hematoma | 2 | 2015 | 768 | 0.040 |
Why?
|
| Skull Base | 1 | 2022 | 292 | 0.040 |
Why?
|
| Wound Healing | 1 | 2011 | 2805 | 0.040 |
Why?
|
| Nerve Regeneration | 1 | 2005 | 795 | 0.040 |
Why?
|
| Tissue Embedding | 2 | 2013 | 42 | 0.040 |
Why?
|
| Hypertrophy | 2 | 2012 | 561 | 0.040 |
Why?
|
| Cells, Cultured | 5 | 2019 | 18965 | 0.040 |
Why?
|
| Jaw | 1 | 1999 | 93 | 0.040 |
Why?
|
| Fibrosis | 3 | 2012 | 2049 | 0.040 |
Why?
|
| Poly I-C | 1 | 2019 | 112 | 0.040 |
Why?
|
| Jaw Diseases | 1 | 1999 | 92 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2021 | 7967 | 0.040 |
Why?
|
| Cell Size | 2 | 2012 | 624 | 0.040 |
Why?
|
| Dissection | 2 | 2011 | 298 | 0.040 |
Why?
|
| Larynx | 2 | 2015 | 492 | 0.040 |
Why?
|
| Sheep | 2 | 2012 | 1440 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2008 | 2822 | 0.040 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2002 | 662 | 0.040 |
Why?
|
| Germinal Center | 1 | 2021 | 380 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 2561 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 1702 | 0.040 |
Why?
|
| Catheter Ablation | 1 | 2012 | 2751 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 857 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2003 | 1129 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 1858 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2002 | 1096 | 0.040 |
Why?
|
| Materials Testing | 2 | 2016 | 863 | 0.040 |
Why?
|
| Survival Rate | 4 | 2018 | 12725 | 0.040 |
Why?
|
| Head | 1 | 2024 | 924 | 0.040 |
Why?
|
| Hodgkin Disease | 1 | 2005 | 1378 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2019 | 554 | 0.040 |
Why?
|
| Audiometry | 1 | 2018 | 253 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2021 | 640 | 0.040 |
Why?
|
| Osteogenesis | 2 | 2015 | 1273 | 0.040 |
Why?
|
| Gels | 1 | 2019 | 420 | 0.040 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2002 | 1374 | 0.040 |
Why?
|
| Surgical Instruments | 2 | 2010 | 383 | 0.040 |
Why?
|
| Absorbable Implants | 2 | 2011 | 338 | 0.040 |
Why?
|
| Elasticity | 2 | 2011 | 655 | 0.040 |
Why?
|
| Leiomyosarcoma | 1 | 2001 | 422 | 0.040 |
Why?
|
| Alleles | 2 | 2000 | 6863 | 0.040 |
Why?
|
| Pain | 1 | 2012 | 5073 | 0.040 |
Why?
|
| Regeneration | 1 | 2006 | 1511 | 0.040 |
Why?
|
| Chickens | 2 | 1990 | 859 | 0.040 |
Why?
|
| Apoptosis | 2 | 2013 | 9486 | 0.030 |
Why?
|
| Clonal Anergy | 1 | 2017 | 170 | 0.030 |
Why?
|
| Cytokines | 1 | 1992 | 7396 | 0.030 |
Why?
|
| Japan | 1 | 2021 | 1378 | 0.030 |
Why?
|
| Vestibule, Labyrinth | 1 | 2019 | 234 | 0.030 |
Why?
|
| Oncogenes | 1 | 2022 | 1222 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2003 | 1079 | 0.030 |
Why?
|
| South Africa | 1 | 2022 | 1842 | 0.030 |
Why?
|
| Thyrotropin | 2 | 2012 | 834 | 0.030 |
Why?
|
| Disease Models, Animal | 4 | 2012 | 18252 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 11742 | 0.030 |
Why?
|
| Research Design | 1 | 2012 | 6180 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2018 | 817 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 2691 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2006 | 9318 | 0.030 |
Why?
|
| Osteotomy | 2 | 2011 | 837 | 0.030 |
Why?
|
| Pilot Projects | 3 | 2020 | 8631 | 0.030 |
Why?
|
| Uterine Diseases | 1 | 1996 | 108 | 0.030 |
Why?
|
| Mouth | 1 | 2018 | 381 | 0.030 |
Why?
|
| Hemorrhage | 2 | 2011 | 3424 | 0.030 |
Why?
|
| DNA Primers | 1 | 2000 | 2819 | 0.030 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2015 | 43 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2019 | 1351 | 0.030 |
Why?
|
| Calcitonin | 2 | 2008 | 329 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 1600 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2003 | 2208 | 0.030 |
Why?
|
| Hysterectomy | 1 | 2000 | 857 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1626 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2016 | 1310 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 550 | 0.030 |
Why?
|
| Canada | 1 | 2020 | 2122 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1993 | 10766 | 0.030 |
Why?
|
| Rats | 5 | 2010 | 23742 | 0.030 |
Why?
|
| Radiotherapy | 2 | 2012 | 1499 | 0.030 |
Why?
|
| Survival Analysis | 4 | 2010 | 10090 | 0.030 |
Why?
|
| Mice | 5 | 2023 | 81525 | 0.030 |
Why?
|
| Certification | 1 | 2017 | 418 | 0.030 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2001 | 954 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2019 | 1251 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 2850 | 0.030 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2013 | 59 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 1560 | 0.030 |
Why?
|
| Estrogens | 1 | 2000 | 1522 | 0.030 |
Why?
|
| Rats, Inbred Lew | 2 | 2006 | 1157 | 0.030 |
Why?
|
| Automation | 1 | 2015 | 586 | 0.030 |
Why?
|
| Genotype | 2 | 2014 | 12990 | 0.030 |
Why?
|
| Age Factors | 3 | 2019 | 18395 | 0.030 |
Why?
|
| Maxilla | 1 | 2016 | 494 | 0.030 |
Why?
|
| Phylogeny | 1 | 2000 | 2811 | 0.030 |
Why?
|
| Uridine | 1 | 1993 | 141 | 0.030 |
Why?
|
| Hospitals, General | 1 | 2017 | 798 | 0.030 |
Why?
|
| Cochlea | 1 | 2019 | 845 | 0.030 |
Why?
|
| Massachusetts | 2 | 2017 | 8830 | 0.030 |
Why?
|
| RNA | 2 | 1993 | 2726 | 0.030 |
Why?
|
| Rhinometry, Acoustic | 1 | 2012 | 8 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2007 | 2281 | 0.020 |
Why?
|
| Mitotic Index | 1 | 2012 | 162 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2006 | 2422 | 0.020 |
Why?
|
| Monocytes | 1 | 2021 | 2570 | 0.020 |
Why?
|
| Microfilament Proteins | 2 | 1988 | 1134 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2013 | 277 | 0.020 |
Why?
|
| Cancer Vaccines | 1 | 2019 | 1051 | 0.020 |
Why?
|
| Bone Density | 2 | 2015 | 3551 | 0.020 |
Why?
|
| Leucine | 1 | 1993 | 548 | 0.020 |
Why?
|
| Chernobyl Nuclear Accident | 1 | 2011 | 15 | 0.020 |
Why?
|
| Age Distribution | 2 | 2007 | 2880 | 0.020 |
Why?
|
| Myoblasts, Skeletal | 1 | 2011 | 75 | 0.020 |
Why?
|
| Photochemical Processes | 1 | 2011 | 86 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2017 | 909 | 0.020 |
Why?
|
| Mass Screening | 1 | 2007 | 5428 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2019 | 3162 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2021 | 4003 | 0.020 |
Why?
|
| Femoral Neoplasms | 1 | 2011 | 84 | 0.020 |
Why?
|
| Ukraine | 1 | 2011 | 149 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2020 | 2651 | 0.020 |
Why?
|
| Rose Bengal | 1 | 2011 | 115 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 7407 | 0.020 |
Why?
|
| Cell Nucleus Size | 1 | 2010 | 11 | 0.020 |
Why?
|
| Cell Nucleus Shape | 1 | 2010 | 16 | 0.020 |
Why?
|
| Viscosity | 1 | 2011 | 336 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 2013 | 635 | 0.020 |
Why?
|
| Spectrin | 1 | 1990 | 170 | 0.020 |
Why?
|
| Steel | 1 | 2010 | 27 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 2645 | 0.020 |
Why?
|
| Facial Nerve Diseases | 1 | 2010 | 49 | 0.020 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2011 | 126 | 0.020 |
Why?
|
| Hair Diseases | 1 | 2010 | 72 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 899 | 0.020 |
Why?
|
| Prevalence | 2 | 2022 | 15732 | 0.020 |
Why?
|
| Cranial Nerves | 1 | 2010 | 98 | 0.020 |
Why?
|
| Cell Nucleolus | 1 | 2010 | 156 | 0.020 |
Why?
|
| Hemostasis, Surgical | 1 | 2010 | 126 | 0.020 |
Why?
|
| Molecular Weight | 2 | 1989 | 2186 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 8181 | 0.020 |
Why?
|
| Mastoid | 1 | 2009 | 100 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2019 | 12463 | 0.020 |
Why?
|
| Solubility | 1 | 1990 | 1091 | 0.020 |
Why?
|
| Cell Shape | 1 | 2010 | 371 | 0.020 |
Why?
|
| Chick Embryo | 1 | 1990 | 982 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 2 | 2010 | 2645 | 0.020 |
Why?
|
| Skull | 1 | 2013 | 818 | 0.020 |
Why?
|
| Bone Plates | 1 | 2011 | 466 | 0.020 |
Why?
|
| HIV Infections | 2 | 2007 | 17351 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5486 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 1992 | 1248 | 0.020 |
Why?
|
| Infant, Newborn | 3 | 2022 | 26198 | 0.020 |
Why?
|
| Watchful Waiting | 1 | 2012 | 491 | 0.020 |
Why?
|
| Electrophoresis | 1 | 2008 | 227 | 0.020 |
Why?
|
| Palpation | 1 | 2008 | 166 | 0.020 |
Why?
|
| Bone Screws | 1 | 2011 | 532 | 0.020 |
Why?
|
| Genomics | 1 | 2024 | 5821 | 0.020 |
Why?
|
| Collagen | 1 | 2016 | 2638 | 0.020 |
Why?
|
| Body Temperature | 1 | 2011 | 781 | 0.020 |
Why?
|
| Nose | 1 | 2011 | 521 | 0.020 |
Why?
|
| Benzamides | 1 | 2013 | 1370 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 2423 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2009 | 410 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5247 | 0.020 |
Why?
|
| Photosensitizing Agents | 1 | 2011 | 623 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15631 | 0.020 |
Why?
|
| Keratin-20 | 1 | 2006 | 31 | 0.020 |
Why?
|
| Mesoderm | 1 | 2009 | 674 | 0.020 |
Why?
|
| Breast Neoplasms | 3 | 2022 | 21012 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3416 | 0.020 |
Why?
|
| Keratin-7 | 1 | 2006 | 55 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2015 | 2242 | 0.020 |
Why?
|
| Mucin-2 | 1 | 2006 | 50 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2008 | 945 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 12059 | 0.020 |
Why?
|
| Cell Survival | 2 | 2006 | 5791 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 1835 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 360 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2455 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2011 | 1528 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 1161 | 0.020 |
Why?
|
| Disease Management | 1 | 2015 | 2508 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4369 | 0.020 |
Why?
|
| Tissue Engineering | 2 | 2006 | 1868 | 0.010 |
Why?
|
| Rhabdomyosarcoma | 1 | 2007 | 358 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1992 | 2113 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 2865 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2005 | 826 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2011 | 1165 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1992 | 1961 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2016 | 2223 | 0.010 |
Why?
|
| Adenoidectomy | 1 | 2005 | 167 | 0.010 |
Why?
|
| Chromatin | 1 | 2016 | 2960 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2002 | 5146 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5671 | 0.010 |
Why?
|
| Keratin-10 | 1 | 2003 | 8 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2006 | 629 | 0.010 |
Why?
|
| Species Specificity | 1 | 1988 | 2414 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2006 | 562 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1988 | 2469 | 0.010 |
Why?
|
| Lymphoma | 1 | 2013 | 1901 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2008 | 1880 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2006 | 903 | 0.010 |
Why?
|
| Maxillary Diseases | 1 | 2003 | 48 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2004 | 350 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2019 | 23445 | 0.010 |
Why?
|
| Neurons | 1 | 2023 | 9463 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2010 | 2358 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2004 | 361 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1988 | 1967 | 0.010 |
Why?
|
| Software | 1 | 2017 | 4434 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2010 | 1264 | 0.010 |
Why?
|
| DNA | 2 | 1996 | 7212 | 0.010 |
Why?
|
| Nanostructures | 1 | 2008 | 553 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2013 | 2009 | 0.010 |
Why?
|
| Piperazines | 1 | 2013 | 2523 | 0.010 |
Why?
|
| Carbon | 1 | 2006 | 666 | 0.010 |
Why?
|
| SEER Program | 1 | 2007 | 1450 | 0.010 |
Why?
|
| Mandibular Diseases | 1 | 2003 | 119 | 0.010 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2009 | 801 | 0.010 |
Why?
|
| Hyphae | 1 | 2002 | 52 | 0.010 |
Why?
|
| Actins | 2 | 2006 | 2050 | 0.010 |
Why?
|
| Antibodies | 1 | 1990 | 2418 | 0.010 |
Why?
|
| Phosphorylation | 2 | 1990 | 8320 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1992 | 6534 | 0.010 |
Why?
|
| Cattle | 1 | 1988 | 3849 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2011 | 1671 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1986 | 1463 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 1992 | 3208 | 0.010 |
Why?
|
| Publishing | 1 | 2009 | 833 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 2003 | 292 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2017 | 6567 | 0.010 |
Why?
|
| Informed Consent | 1 | 2008 | 1008 | 0.010 |
Why?
|
| Arthralgia | 1 | 2005 | 461 | 0.010 |
Why?
|
| Risk Factors | 3 | 2019 | 74206 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 22169 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 2005 | 668 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1992 | 4352 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2006 | 1154 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6485 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1993 | 2298 | 0.010 |
Why?
|
| Polyomavirus Infections | 1 | 2002 | 194 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2678 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 2001 | 287 | 0.010 |
Why?
|
| Pelvic Neoplasms | 1 | 2001 | 247 | 0.010 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 438 | 0.010 |
Why?
|
| Aneuploidy | 1 | 2003 | 551 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 7594 | 0.010 |
Why?
|
| Contrast Media | 1 | 2012 | 5311 | 0.010 |
Why?
|
| Colposcopy | 1 | 1999 | 150 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 3087 | 0.010 |
Why?
|
| Endometrial Hyperplasia | 1 | 1999 | 97 | 0.010 |
Why?
|
| Sex Factors | 1 | 2012 | 10552 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2009 | 4141 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2006 | 2932 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 2003 | 607 | 0.010 |
Why?
|
| Cell Line | 1 | 1992 | 15601 | 0.010 |
Why?
|
| Microsurgery | 1 | 2003 | 795 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 26125 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 3429 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1993 | 4320 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 9000 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1999 | 1572 | 0.010 |
Why?
|
| Smoking | 1 | 2012 | 9053 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 11118 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 3448 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2003 | 2639 | 0.010 |
Why?
|
| Inflammation | 1 | 1992 | 10773 | 0.010 |
Why?
|
| Registries | 1 | 2007 | 8224 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 14414 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 15842 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1989 | 297 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1989 | 262 | 0.010 |
Why?
|
| Phosphopeptides | 1 | 1989 | 240 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1989 | 1541 | 0.000 |
Why?
|
| Substrate Specificity | 1 | 1989 | 1791 | 0.000 |
Why?
|